Skip to content
Search

Latest Stories

'Pharmacogenomic testing should be deployed across NHS'

The recently published report by the British Pharmacological Society and the Royal College of Physicians encourages use of pharmacogenomic testing across the NHS to improve patient outcomes. 

Personalised prescribing: using pharmacogenomics to improve patient outcomes report explains how pharmacogenomic testing should be deployed across the NHS to ensure all patients have an equal chance of being prescribed a medicine at a dose that is likely to be safe and effective for them.

Commenting on the publication, Ravi Sharma, director for England at the Royal Pharmaceutical Society, who was on the report’s working group, said: “This important report, produced by a joint working party involving RPS, highlights the pivotal role that pharmacists play in the successful implementation of pharmacogenomics services across England, Scotland and Wales.

“We have seen huge progress across England with NHS Genomic Medicine Service Alliances set up that oversee and coordinate the embedding of genomics into mainstream clinical care in seven regions.

“Pharmacists have the knowledge, skills and abilities to provide the precision dosing and therapeutic drug monitoring that connects genomic testing with medicines optimisation, and so will play a central part in delivering the advances in personalised medicine that are set to revolutionise patient care.

“Pharmacy teams across the whole system have a critical role to play, particularly in primary care where most prescribing and dispensing takes place for patients. We want to see infrastructure established to create a pharmacogenomics service in every Integrated Care System in England, as recommended in the report, with pharmacists playing a critical leadership role in the multidisciplinary team embedded into clinical pathways across specialties to inform care for individual patients.

“Appropriate workforce planning for current and future generations of the pharmacy workforce is key to achieving this, so the full potential of providing pharmacogenomics care across settings can be realised. The future is within reach and the impact of integrated working, improved care, reduced medicines-related admissions to hospital and better benefits for patients from their medicines through pharmacogenomics is a truly exciting and inspiring prospect.”

More For You

​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less